FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | +7.7% | 4,125 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | +30.0% | 4,125 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -33.3% | 4,125 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | 0.0% | 4,125 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -37.5% | 4,125 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | +33.3% | 4,125 | +15.1% | 0.00% | – |
| Q2 2018 | $18,000 | 0.0% | 3,583 | 0.0% | 0.00% | – |
| Q1 2018 | $18,000 | -18.2% | 3,583 | 0.0% | 0.00% | – |
| Q4 2017 | $22,000 | -45.0% | 3,583 | -50.6% | 0.00% | – |
| Q3 2017 | $40,000 | +17.6% | 7,252 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | +61.9% | 7,252 | +68.2% | 0.00% | – |
| Q1 2017 | $21,000 | -4.5% | 4,311 | +115.8% | 0.00% | – |
| Q4 2016 | $22,000 | +29.4% | 1,998 | +5.9% | 0.00% | – |
| Q3 2016 | $17,000 | +54.5% | 1,887 | +7.2% | 0.00% | – |
| Q2 2016 | $11,000 | 0.0% | 1,760 | +4.1% | 0.00% | – |
| Q1 2016 | $11,000 | -15.4% | 1,690 | +8.5% | 0.00% | – |
| Q4 2015 | $13,000 | +18.2% | 1,558 | +5.8% | 0.00% | – |
| Q3 2015 | $11,000 | -21.4% | 1,473 | +9.8% | 0.00% | – |
| Q2 2015 | $14,000 | – | 1,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|